Extended treatment response to imatinib in Rosai‐Dorfman disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Extended treatment response to imatinib in Rosai‐Dorfman disease

Published:2021-03-04 Issue:6 Volume:106 Page:868-870
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Singh Avani¹,Simons Yael²^ORCID,Biren‐Fetz John³,Mohapatra Gayatry⁴,Ni Hongyu⁴,Gaitonde Sujata⁴,Khan Irum²

Affiliation:

1. Department of Medicine University of Illinois at Chicago Chicago IL USA

2. Division of Hematology and Oncology Department of Medicine University of Illinois at Chicago Chicago IL USA

3. Department of Radiology University of Illinois at Chicago Chicago IL USA

4. Department of Pathology University of Illinois at Chicago Chicago IL USA

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13605

Reference5 articles.

1. Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease

2. Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis

3. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease

4. Imatinib as a Treatment Option for Systemic Non-Langerhans Cell Histiocytoses

5. A case of cutaneous Rosai‐Dorfman disease refractory to Imatinib therapy;Gerbhardt C;Arch Dermatol,2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Understanding and Management of Erdheim-Chester Disease;Life Sciences;2024-07

2. Surgical management and outcome of primary intracranial Rosai-Dorfman disease: a single-institute experience and pooled analysis of individual patient data;Neurosurgical Review;2023-03-27

3. Enfermedad de Rosai-Dorfman con afección ganglionar y extraganglionar;Revista Repertorio de Medicina y Cirugía;2022-10-10

4. Thalidomide as treatment of refractory thoracic Rosai‐Dorfman disease;Journal of Clinical Pharmacy and Therapeutics;2021-09-12

5. Extended treatment response to imatinib in Rosai‐Dorfman disease;European Journal of Haematology;2021-03-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3